29th Annual Meeting of the German Drug Utilisation Research Group (GAA)
Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
24.11. - 25.11.2022, Münster
Abstracts
Meeting Abstract
(22gaa01)
[Full Text]
Effect of guideline-recommended pharmaceutical therapy on osteoporosis-associated fractures exemplified by the proximal humerus.
Köppe J, Stolberg-Stolberg J, Rischen R, Freistühler M, Faldum A, Raschke MJ, Katthagen JC[Full Text]
Meeting Abstract
(22gaa02)
[Full Text]
Outpatient Antibiotic Prescribing in Early Life: A Population-Based Study Comparing Birth Cohorts from Denmark and Germany
Scholle O, Rasmussen L, Reilev M, Viebrock J, Haug U[Full Text]
Meeting Abstract
(22gaa03)
[Full Text]
Characterization of incidence, prevalence, and treatment patterns of chronic lymphocytic leukemia based on German healthcare claims data
Wartmann H, Schneller S, Scharenberg M, Struck K, Deiters B, Heidler T, Schmitz N, Volmer T[Full Text]
Meeting Abstract
(22gaa04)
[Full Text]
Scientific Application of the Web-Based Health Portal VITERIO for the Acquisition and Analysis of Digital Outcome Parameters
Bachmeier B, Salm S, Melchart D[Full Text]
Meeting Abstract
(22gaa05)
[Full Text]
Expanding vaccination services in pharmacies – key findings from a survey on COVID-19 vaccinations in Germany
Heydarpour R, Vu H, Urban JN, Wohlleben M[Full Text]
Meeting Abstract
(22gaa06)
[Full Text]
Opportunities for implementing targeted vaccination management in oncological patients in hospital setting
Völker A, Urban JN, Kron F, Wohlleben M[Full Text]
Meeting Abstract
(22gaa07)
[Full Text]
WOLGA: Further development, optimization and application of an algorithm for the detection of serious adverse drug reactions based on claims data - first results of a sub-analysis focusing on clostridium difficile infections
Christ P, Rischke N, Dubrall D, Scholle O, Stausberg J, Haug U, Sachs B[Full Text]
Meeting Abstract
(22gaa08)
[Full Text]
Characteristics and completeness of spontaneous reports of opioid-associated abuse, dependence or withdrawal based on EudraVigilance data in Germany: Reporting characteristics of pharmacists and other reporters
Jobski K, Bantel C, Hoffmann F[Full Text]
Meeting Abstract
(22gaa09)
[Full Text]
Information deficits in liver-related contraindications – Analysis of clarity and codability in SmPCs/PI of major drug markets
Weisbach L, Schuster AK, Hartmann M, Fromm MF, Maas R, Farker K[Full Text]
Meeting Abstract
(22gaa10)
[Full Text]
A prospective study on the immunogenicity of different vaccines-schemes against SARS-CoV-2 in hospital staff – Insights from the Helios Hildesheim COVID-19 Vaccination Study (HelCO-Vac)
Dedroogh S, Graf K, Schmiedl S, Thürmann P, Appelbaum S, Ostermann T, Koß R, Theis C, Zia Z, Tebbenjohanns J, Thal S, Dedroogh M[Full Text]
Meeting Abstract
(22gaa11)
[Full Text]
Application of herbal medicines in mental symptom load – data analysis of a pharmaco-epidemiological and health services research study
Salm S, Schulz A, Kelber O, Raskopf E, Shah-Hosseini K, Mösges R, Bachmeier BE[Full Text]
Meeting Abstract
(22gaa12)
[Full Text]
Relevance of complexity factors that cannot be derived from medication schedules
Schmidt SJ, Wurmbach VS, Lampert A, Bernard S, Meid AD, Frick E, Metzner M, Wilm S, Mortsiefer A, Bücker B, Altiner A, Sparenberg L, Szecsenyi J, Peters-Klimm F, Kaufmann-Kolle P, Haefeli WE, Seidling HM, Thürmann PA[Full Text]
Meeting Abstract
(22gaa13)
[Full Text]
Achievements of the COFRAIL intervention study with focus on shared prioritisation and deprescribing by means of family conferences to improve patient safety in frail elderly with polypharmacy
Gogolin M, Bencheva V, Schmiedl S, Mortsiefer A, Wilm S, Wollny A, Drewelow E, Ritzke M, Altiner A, Icks A, Meyer G, Wiese B, Thürmann PA, COFRAIL study group[Full Text]
Meeting Abstract
(22gaa14)
[Full Text]
Documentation and timeliness of the nationwide standardized medication plan for patients in an emergency department
Schuster AK, Weisbach L, Stumme C, Behringer W, Hartmann M, Farker K[Full Text]
Meeting Abstract
(22gaa15)
[Full Text]
A methodical approach to determine possible nocebo and placebo effects of Covid-19 vaccinations
Hach I, Bunila-Yuwang F, Sattler A, Brucker C[Full Text]
Meeting Abstract
(22gaa16)
[Full Text]
Do systemic adverse events following the first dose of mRNA vaccine BNT162b2 administered early to a hospital staff sample differ from the approval study sample?
Bunila-Yuwang F, Brucker C, Sattler A, Hach I[Full Text]
Meeting Abstract
(22gaa17)
[Full Text]
Should suicidal adolescents be monitored for drug use at the beginning of a hospital stay?
Hach I, Bertsch T, Nonell P[Full Text]
Meeting Abstract
(22gaa18)
[Full Text]
Medication adaptation as a heat protection concept – preparing the outpatient sector for heat waves
van de Sand H, Heck J, Krause O, Poppe A, Bunz M, van Baal K, Müller B, Meyer I[Full Text]
Meeting Abstract
(22gaa19)
[Full Text]
Prescription of oral antiepileptic drugs in Germany between 2010 and 2020
Scholz K, Köster I, Schubert I, Meyer I[Full Text]
Meeting Abstract
(22gaa20)
[Full Text]
Complexity of outpatient drug therapy over a decade of life: consequences for digitalisation in healthcare
Lappe V, Schubert I, Grandt D[Full Text]
Meeting Abstract
(22gaa21)
[Full Text]
Prioritisation and identification of adverse drug reactions in routinely collected electronic data sources during hospitalisation: A RAND survey
Boehmer AM, Haerdtlein A, Dreischulte T, Jaehde U[Full Text]
Meeting Abstract
(22gaa22)
[Full Text]
The effects of Covid-19 and discount contracts on the current design of regional drug contracts in conception and controlling
Schuster R, Emcke T, Fabian S[Full Text]
Meeting Abstract
(22gaa23)
[Full Text]
Effect of direct healthcare professional communications on prescribing behaviour
Köberle U, Grohmann R, Belz M, Greil W, Gundert-Remy U, Degner D[Full Text]
